TALE-PvuII fusion proteins - Novel tools for gene targeting

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Yanik, Mert ^a   Alzubi, Jamal ^b   Lahaye, Thomas ^c   Cathomen, Toni ^b   Pingoud, Alfred ^a   Wende, Wolfgang ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NUCLEASE; PROTEIN FOKI; PROTEIN PVUII; PROTEIN TALE; PROTEIN TALE PVUII; PROTEIN VARIANT; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CATALYSIS; CONTROLLED STUDY; CYTOTOXICITY; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN ISOLATION;

BINDING SITES; CELL LINE; DNA CLEAVAGE; DNA-BINDING PROTEINS; DNA-CYTOSINE METHYLASES; GENE TARGETING; HOMEODOMAIN PROTEINS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY;

EID: 84891942333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082539     Document Type: Article

References (77)

1. Mussolino C, Cathomen T (2013) RNA guides genome engineering. Nat Biotechnol 31: 208-209. doi: 10.1038/nbt.2527. PubMed: 23471067.
2. Oost Jvd (2013) New Tool for Genome Surgery. Science 339: 768-770
3. Pingoud A, Wende W (2011) Generation of novel nucleases with extended specificity by rational and combinatorial strategies. Chembiochem 12: 1495-1500. doi: 10.1002/cbic.201100055. PubMed: 21560218.
4. Gaj T, Gersbach CA, Barbas CF 3rd (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31: 397-405. doi: 10.1016/j.tibtech.2013.04.004. PubMed: 23664777.
5. Pauwels K, Podevin N, Breyer D, Carroll D, Herman P (2013) Engineering nucleases for gene targeting: safety and regulatory considerations. N Biotechnol: ([MedlinePgn:]) doi: 10.1016/j.nbt. 2013.1007.1001. PubMed: 23851284.
6. Marcaida MJ, Muñoz IG, Blanco FJ, Prieto J, Montoya G (2010) Homing endonucleases: from basics to therapeutic applications. Cell Mol Life Sci 67: 727-748. doi: 10.1007/s00018-009-0188-y. PubMed: 19915993.
7. Silva G, Poirot L, Galetto R, Smith J, Montoya G et al. (2011) Meganucleases and other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene. Therapy - Curr Gene Ther 11: 11-27. doi: 10.2174/156652311794520111.
8. Stoddard B, Scharenberg A, Monnat R (2008) Advances in engineering homing endonucleases for gene targeting: ten years after structures. In: R BertolottiK Ozawa. Progress in gene therapy: autologous and cancer stem cell gene therapy. Hackensack: World Scientific Press. pp. 135-167.
9. Camenisch TD, Brilliant MH, Segal DJ (2008) Critical parameters for genome editing using zinc finger nucleases. Mini Rev Med Chem 8: 669-676. doi: 10.2174/138955708784567458. PubMed: 18537722.
10. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11: 636-646. doi: 10.1038/nrg2842. PubMed: 20717154.
11. Händel EM, Cathomen T (2011) Zinc-Finger Nuclease Based Genome Surgery: It's all About Specificity. Curr Gene Ther 11: 28-37. doi: 10.2174/156652311794520120. PubMed: 21182467.
12. Rahman SH, Maeder ML, Joung JK, Cathomen T (2011) Zinc-finger nucleases for somatic gene therapy: the next frontier. Hum Gene Ther 22: 925-933. doi: 10.1089/hum.2011.087. PubMed: 21631241.
13. Carroll D (2011) Zinc-finger nucleases: a panoramic view. Curr Gene Ther 11: 2-10. doi: 10.2174/156652311794520076. PubMed: 21182468.
14. Carroll D (2011) Genome engineering with zinc-finger nucleases. Genetics 188: 773-782. doi: 10.1534/genetics.111.131433. PubMed: 21828278.
15. Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 93: 1156-1160. doi: 10.1073/pnas.93.3.1156. PubMed: 8577732. (Pubitemid 26052857)
16. Klug A (2010) The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem 79: 213-231. doi: 10.1146/annurev-biochem-010909-095056. PubMed: 20192761.
17. Boch J, Bonas U (2010) Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol 48: 419-436. doi: 10.1146/annurev-phyto-080508-081936. PubMed: 19400638.
18. Römer P, Hahn S, Jordan T, Strauss T, Bonas U et al. (2007) Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene. Science 318: 645-648. doi: 10.1126/science. 1144958. PubMed: 17962564.
19. Scholze H, Boch J (2011) TAL effectors are remote controls for gene activation. Curr Opin Microbiol 14: 47-53. doi: 10.1016/j.mib. 2010.12.001. PubMed: 21215685.
20. Streubel J, Blücher C, Landgraf A, Boch J (2012) TAL effector RVD specificities and efficiencies. Nat Biotechnol 30: 593-595. doi: 10.1038/ nbt.2304. PubMed: 22781676.
21. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S et al. (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326: 1509-1512. doi: 10.1126/science.1178811. PubMed: 19933107.
22. Moscou MJ, Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326: 1501. doi: 10.1126/science. 1178817. PubMed: 19933106.
23. Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F et al. (2010) TAL Effector Nucleases Create Targeted DNA Double-strand Breaks. Genetics 186: 757-761. doi: 10.1534/genetics.110.120717. PubMed: 20660643.
24. Li T, Huang S, Jiang WZ, Wright D, Spalding MH et al. (2011) TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res 39: 359-372. PubMed: 20699274.
25. Miller JC, Tan S, Qiao G, Barlow KA, Wang J et al. (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29: 143-148. doi: 10.1038/nbt.1755. PubMed: 21179091.
26. Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T et al. (2011) A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39: 9283-9293. doi: 10.1093/nar/gkr597. PubMed: 21813459.
27. Zhang F, Cong L, Lodato S, Kosuri S, Church GM et al. (2011) Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29: 149-153. doi: 10.1038/nbt. 1775. PubMed: 21248753.
28. Wang Z, Li J, Huang H, Wang G, Jiang M et al. (2012) An Integrated Chip for the High-Throughput Synthesis of Transcription Activator-like Effectors. Angew Chem - Int Ed Engl: 1-5.
29. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD et al. (2012) FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 30: 460-465. doi: 10.1038/nbt.2170. PubMed: 22484455.
30. Briggs AW, Rios X, Chari R, Yang L, Zhang F et al. (2012) Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res 40: e117. doi: 10.1093/nar/gks608. PubMed: 22740649.
31. Perez-Pinera P, Ousterout DG, Gersbach CA (2012) Advances in targeted genome editing. Curr Opin Chem Biol 16: 268-277. doi: 10.1016/j.cbpa.2012.06. 007. PubMed: 22819644.
32. Clark KJ, Voytas DF, Ekker SC (2011) A TALE of two nucleases: gene targeting for the masses? Zebrafish 8: 147-149. doi: 10.1089/zeb. 2011.9993. PubMed: 21929364.
33. Bogdanove AJ, Voytas DF (2011) TAL effectors: customizable proteins for DNA targeting. Science 333: 1843-1846. doi: 10.1126/science. 1204094. PubMed: 21960622.
34. Mak AN, Bradley P, Bogdanove AJ, Stoddard BL (2013) TAL effectors: function, structure, engineering and applications. Curr Opin Struct Biol 23: 93-99. doi: 10.1016/j.sbi.2012.11.001. PubMed: 23265998.
35. DeFrancesco L (2011) Move over ZFNs. Nat Biotechnol 29: 681-684. doi: 10.1038/nbt.1935. PubMed: 21822235.
36. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821. doi: 10.1126/science. 1225829. PubMed: 22745249.
37. Mali P, Yang L, Esvelt KM, Aach J, Guell M et al. (2013) RNA-Guided Human Genome Engineering via Cas9. Science 339: 823-826. doi: 10.1126/science. 1232033. PubMed: 23287722.
38. Cong L, Ran FA, Cox D, Lin S, Barretto R et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823. doi: 10.1126/science.1231143. PubMed: 23287718.
39. Szybalski W, Kim SC, Hasan N, Podhajska AJ (1991) Class-IIS restriction enzymes-a review. Gene 100: 13-26. doi: 10.1016/0378-1119(91)90345-C. PubMed: 2055464.
40. Pingoud A, Jeltsch A (2001) Structure and function of type II restriction endonucleases. Nucleic Acids Res 29: 3705-3727. doi: 10.1093/nar/ 29.18.3705. PubMed: 11557805. (Pubitemid 32910514)
41. Sugisaki H, Kanazawa S (1981) New restriction endonucleases from Flavobacterium okeanokoites (FokI) and Micrococcus luteus (MluI). Gene 16: 73-78. doi: 10.1016/0378-1119(81)90062-7. PubMed: 6282705. (Pubitemid 12132036)
42. Bitinaite J, Wah DA, Aggarwal AK, Schildkraut I (1998) FokI dimerization is required for DNA cleavage. Proc Natl Acad Sci U S A 95: 10570-10575. doi: 10.1073/pnas.95.18.10570. PubMed: 9724744. (Pubitemid 28413108)
43. Vanamee ES, Santagata S, Aggarwal AK (2001) FokI requires two specific DNA sites for cleavage. J Mol Biol 309: 69-78. doi: 10.1006/ jmbi.2001.4635. PubMed: 11491302. (Pubitemid 32553508)
44. Halford SE, Catto LE, Pernstich C, Rusling DA, Sanders KL (2011) The reaction mechanism of FokI excludes the possibility of targeting zinc finger nucleases to unique DNA sites. Biochem Soc Trans 39: 584-588. doi: 10.1042/BST0390584. PubMed: 21428944.
45. Miller JC, Holmes MC, Wang J, Guschin DY, Lee YL et al. (2007) An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25: 778-785. doi: 10.1038/nbt1319. PubMed: 17603475. (Pubitemid 47052191)
46. Szczepek M, Brondani V, Büchel J, Serrano L, Segal DJ et al. (2007) Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 25: 786-793. doi: 10.1038/nbt1317. PubMed: 17603476. (Pubitemid 47052189)
47. Gabriel R, Lombardo A, Arens A, Miller JC, Genovese P et al. (2011) An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29: 816-823. doi: 10.1038/nbt.1948. PubMed: 21822255.
48. Pattanayak V, Ramirez CL, Joung JK, Liu DR (2011) Revealing offtarget cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 8: 765-770. doi: 10.1038/nmeth.1670. PubMed: 21822273.
49. Eisenschmidt K, Lanio T, Simoncsits A, Jeltsch A, Pingoud V et al. (2005) Developing a programmed restriction endonuclease for highly specific DNA cleavage. Nucleic Acids Res 33: 7039-7047. doi: 10.1093/nar/gki1009. PubMed: 16356926. (Pubitemid 43125073)
50. Silanskas A, Foss M, Wende W, Urbanke C, Lagunavicius A et al. (2011) Photocaged Variants of the MunI and PvuII Restriction Enzymes. Biochemistry 50: 2800-2807. doi: 10.1021/bi2000609. PubMed: 21410225.
51. Chiang WC, Geel TM, Altintas MM, Sever S, Ruiters MH et al. (2010) Establishment of protein delivery systems targeting podocytes. PLOS ONE 5: e11837. doi: 10.1371/journal.pone.0011837. PubMed: 20686602.
52. Geel TM, Meiss G, van der Gun BT, Kroesen BJ, de Leij LF et al. (2009) Endonucleases induced TRAIL-insensitive apoptosis in ovarian carcinoma cells. Exp Cell Res 315: 2487-2495. doi: 10.1016/j.yexcr. 2009.06.011. PubMed: 19540229.
53. Fonfara I, Curth U, Pingoud A, Wende W (2012) Creating highly specific nucleases by fusion of active restriction endonucleases and catalytically inactive homing endonucleases. Nucleic Acids Res 40: 847-860. doi: 10.1093/nar/gkr845. PubMed: 21965534.
54. Schierling B, Dannemann N, Gabsalilow L, Wende W, Cathomen T et al. (2012) A novel zinc-finger nuclease platform with a sequencespecific cleavage module. Nucleic Acids Res 40: 2623-2638. doi: 10.1093/nar/gkr1112. PubMed: 22135304.
55. Kleinstiver BP, Wolfs JM, Kolaczyk T, Roberts AK, Hu SX et al. (2012) Monomeric site-specific nucleases for genome editing. Proc Natl Acad Sci U S A 109: 8061-8066. doi: 10.1073/pnas.1117984109. PubMed: 22566637.
56. Beurdeley M, Bietz F, Li J, Thomas S, Stoddard T et al. (2013) Compact designer TALENs for efficient genome engineering. Nat Commun 4: 1762. doi: 10.1038/ncomms2782. PubMed: 23612303.
57. Gabsalilow L, Schierling B, Friedhoff P, Pingoud A, Wende W (2013) Site- and strand-specific nicking of DNA by fusion proteins derived from MutH and I-SceI or TALE repeats. Nucleic Acids Res 41: e83. doi: 10.1093/nar/gkt080. PubMed: 23408850.
58. Zhu Z, Blanchard A, Xu S-Y, Wei H, Zhang P et al. (2009) High fidelity restriction endonucleases. US Patent 20090029376.
59. Simoncsits A, Tjörnhammar ML, Raskó T, Kiss A, Pongor S (2001) Covalent joining of the subunits of a homodimeric type II restriction endonuclease: single-chain PvuII endonuclease. J Mol Biol 309: 89-97. doi: 10.1006/jmbi.2001.4651. PubMed: 11491304. (Pubitemid 32553510)
60. Pace CN, Vajdos F, Fee L, Grimsley G, Gray T (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4: 2411-2423. doi: 10.1002/pro.5560041120. PubMed: 8563639.
61. Oelgeschläger T, Geiger R, Rüter T, Alves J, Fliess A et al. (1990) Probing the function of individual amino acid residues in the DNA binding site of the EcoRI restriction endonuclease by analysing the toxicity of genetically engineered mutants. Gene 89: 19-27. doi: 10.1016/0378-1119(90)90201- 2. PubMed: 2142667. (Pubitemid 20209011)
62. Söllü C, Pars K, Cornu TI, Thibodeau-Beganny S, Maeder ML et al. (2010) Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion. Nucleic Acids Res 38: 8269-8276. doi: 10.1093/nar/gkq720. PubMed: 20716517.
63. Cornu TI, Thibodeau-Beganny S, Guhl E, Alwin S, Eichtinger M et al. (2008) DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases. Mol Ther 16: 352-358. doi: 10.1038/ sj.mt.6300357. PubMed: 18026168. (Pubitemid 351187464)
64. Alwin S, Gere MB, Guhl E, Effertz K, Barbas CF 3rd et al. (2005) Custom zinc-finger nucleases for use in human cells. Mol Ther 12: 610-617. doi: 10.1016/j.ymthe.2005.06.094. PubMed: 16039907. (Pubitemid 41350142)
65. Kay S, Hahn S, Marois E, Hause G, Bonas U (2007) A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science 318: 648-651. doi: 10.1126/science.1144956. PubMed: 17962565. (Pubitemid 350014839)
66. Bonas U, Stall RE, Staskawicz B (1989) Genetic and structural characterization of the avirulence gene avrBs3 from Xanthomonas campestris pv. vesicatoria. Mol Gen Genet 218: 127-136. doi: 10.1007/ BF00330575. PubMed: 2550761.
67. McMahon MA, Rahdar M, Porteus M (2012) Gene editing: not just for translation anymore. Nat Methods 9: 28-31. PubMed: 22205513.
68. Rouet P, Smih F, Jasin M (1994) Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci U S A 91: 6064-6068. doi: 10.1073/pnas. 91.13.6064. PubMed: 8016116. (Pubitemid 24188283)
69. Kaczorowski T, Skowron P, Podhajska AJ (1989) Purification and characterization of the FokI restriction endonuclease. Gene 80: 209-216. doi: 10.1016/0378-1119(89)90285-0. PubMed: 2583511. (Pubitemid 19226577)
70. Pernstich C, Halford SE (2012) Illuminating the reaction pathway of the FokI restriction endonuclease by fluorescence resonance energy transfer. Nucleic Acids Res 40: 1203-1213. doi: 10.1093/nar/gkr809. PubMed: 21993298.
71. Rusling DA, Laurens N, Pernstich C, Wuite GJ, Halford SE (2012) DNA looping by FokI: the impact of synapse geometry on loop topology at varied site orientations. Nucleic Acids Res 40: 4977-4987. doi: 10.1093/nar/gks183. PubMed: 22362745.
72. Catto LE, Ganguly S, Milsom SE, Welsh AJ, Halford SE (2006) Protein assembly and DNA looping by the FokI restriction endonuclease. Nucleic Acids Res 34: 1711-1720. doi: 10.1093/nar/gkl076. PubMed: 16556912.
73. Athanasiadis A, Vlassi M, Kotsifaki D, Tucker PA, Wilson KS et al. (1994) Crystal structure of PvuII endonuclease reveals extensive structural homologies to EcoRV. Nat Struct Biol 1: 469-475. doi: 10.1038/nsb0794-469. PubMed: 7664066.
74. Cheng X, Balendiran K, Schildkraut I, Anderson JE (1994) Structure of PvuII endonuclease with cognate. DNA - EMBO J 13: 3927-3935.
75. Pingoud A, Silva GH (2007) Precision genome surgery. Nat Biotechnol 25: 743-744. doi: 10.1038/nbt0707-743. PubMed: 17621297. (Pubitemid 47052180)
76. Mak AN, Bradley P, Cernadas RA, Bogdanove AJ, Stoddard BL (2012) The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335: 716-719. doi: 10.1126/science.1216211. PubMed: 22223736.
77. Galetto R, Duchateau P, Pâques F (2009) Targeted approaches for gene therapy and the emergence of engineered meganucleases. Expert Opin Biol Ther 9: 1289-1303. doi: 10.1517/14712590903213669. PubMed: 19689185.